Howard Mutsando

Toowoomba, QLD, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Historical outcomes for patients with stage IA NLPHL: RGlobal nLPHL One Working Group (GLOW) retrospective analyses.

Historical outcomes for patients with stage IA NLPHL: RGlobal nLPHL One Working Group (GLOW) retrospective analyses.

Journal: Blood advances

Published: February 05, 2026

Historical outcomes for patients with stage IA NLPHL: Global NLPHL One Working Group retrospective analyses.

Historical outcomes for patients with stage IA NLPHL: Global NLPHL One Working Group retrospective analyses.

Journal: Blood advances

Published: February 05, 2026

International Prognostic Score for Nodular Lymphocyte-Predominant Hodgkin Lymphoma.

International Prognostic Score for Nodular Lymphocyte-Predominant Hodgkin Lymphoma.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: March 26, 2024

Diagnosis and management of mantle cell lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance.

Diagnosis and management of mantle cell lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance.

Journal: Internal medicine journal

Published: March 02, 2024

Impact and utility of follicular lymphoma GELF criteria in routine care: an Australasian Lymphoma Alliance study.

Impact and utility of follicular lymphoma GELF criteria in routine care: an Australasian Lymphoma Alliance study.

Journal: Haematologica

Published: October 23, 2023

How comparable are patient outcomes in the "real-world" with populations studied in pivotal AML trials?

How comparable are patient outcomes in the "real-world" with populations studied in pivotal AML trials?

Journal: Blood cancer journal

Published: October 22, 2023

Clinical characteristics of Australian treatment-naïve patients with classical Hodgkin lymphoma from the lymphoma and related diseases registry.

Clinical characteristics of Australian treatment-naïve patients with classical Hodgkin lymphoma from the lymphoma and related diseases registry.

Journal: European journal of haematology

Published: October 13, 2022

Bortezomib use and outcomes for the treatment of multiple myeloma.

Bortezomib use and outcomes for the treatment of multiple myeloma.

Journal: Internal medicine journal

Published: June 28, 2019

Cancer treatment in the extreme elderly: case study of a 100-year-old lymphoma patient.

Cancer treatment in the extreme elderly: case study of a 100-year-old lymphoma patient.

Journal: International journal of hematologic oncology

Published: June 10, 2016

Using HitAlert flow cytometry to detect heparin-induced thrombocytopenia antibodies in a tertiary care hospital.

Using HitAlert flow cytometry to detect heparin-induced thrombocytopenia antibodies in a tertiary care hospital.

Journal: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis

Published: February 23, 2013

High dose methotrexate and extended hours high-flux hemodialysis for the treatment of primary central nervous system lymphoma in a patient with end stage renal disease.

High dose methotrexate and extended hours high-flux hemodialysis for the treatment of primary central nervous system lymphoma in a patient with end stage renal disease.

Journal: American journal of blood research

Published: November 03, 2011

Showing 1-11 of 11

Last Updated: 09/26/2026